{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:58:31Z","timestamp":1787507911363,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P40 OD010996"],"award-info":[{"award-number":["P40 OD010996"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.biologicals.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T09:47:43Z","timestamp":1552902463000},"page":"56-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies"],"prefix":"10.1016","volume":"59","author":[{"given":"Shuyun","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy","family":"Volokhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Rodionova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wirblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias J.","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Chizhikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Dabrazhynetskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2019.03.002_bib1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.virusres.2005.04.004","article-title":"Replication strategies of rabies virus","volume":"111","author":"Finke","year":"2005","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2019.03.002_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","article-title":"The cell biology of rabies virus: using stealth to reach the brain","volume":"8","author":"Schnell","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.biologicals.2019.03.002_bib3","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.biologicals.2019.03.002_bib4","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper - recommendations","volume":"28","author":"World Health Organization","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.03.002_bib5","series-title":"WHO technical report series 941. Geneva, Switzerland","year":"2007"},{"key":"10.1016\/j.biologicals.2019.03.002_bib6","first-page":"1","article-title":"Human rabies prevention-United States: recommendations of the advisory committee on immunization practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.biologicals.2019.03.002_bib7","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2019.03.002_bib8","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.biologicals.2019.03.002_bib9","series-title":"The immunological basis for immunization series. Module 17: rabies","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.biologicals.2019.03.002_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.biologicals.2019.03.002_bib11","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals","author":"Office International des Epizooties (OIE)","year":"2013"},{"key":"10.1016\/j.biologicals.2019.03.002_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2004.12.003","article-title":"A novel rapid fluorescent focus inhibition test for rabies virus using a recombinant rabies virus visualizing a green fluorescent protein","volume":"125","author":"Khawplod","year":"2005","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2019.03.002_bib13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3390\/v6041578","article-title":"Generation of recombinant rabies Virus CVS-11 expressing eGFP applied to the rapid virus neutralization test","volume":"6","author":"Xue","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.biologicals.2019.03.002_bib14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11262-016-1313-2","article-title":"A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro","volume":"52","author":"Luo","year":"2016","journal-title":"Virus Gene"},{"key":"10.1016\/j.biologicals.2019.03.002_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jviromet.2015.03.022","article-title":"A recombinant rabies virus expressing a phosphoprotein-eGFP fusion is rescued and applied to the rapid virus neutralization antibody assay","volume":"219","author":"Tang","year":"2015","journal-title":"J Virol Methods"},{"key":"10.1016\/j.biologicals.2019.03.002_bib16","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2019.03.002_bib17","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.1016\/j.vaccine.2009.09.024","article-title":"A robust lentiviral pseudotype neutralization assay for in-field serosurveillance of rabies and lyssaviruses in Africa","volume":"27","author":"Wright","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2019.03.002_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2014.04.001","article-title":"Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers","volume":"42","author":"Schiffelers","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.03.002_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biologicals.2009.01.001","article-title":"The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines","volume":"37","author":"Kramer","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2019.03.002_bib20","first-page":"37","article-title":"Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use","volume":"2","author":"Kramer","year":"2010","journal-title":"Pharmeur Bio Sci Notes"},{"key":"10.1016\/j.biologicals.2019.03.002_bib21","series-title":"Monograph 0451. European Pharmacopoeia","article-title":"Rabies vaccine (inactivated) for veterinary use","year":"2017"},{"key":"10.1016\/j.biologicals.2019.03.002_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-98-23997","article-title":"Growth of rabies virus in non-nervous tissue culture","volume":"98","author":"Kissling","year":"1958","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.biologicals.2019.03.002_bib23","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1073\/pnas.95.6.3152","article-title":"Rabies virus quasispecies: implications for pathogenesis","volume":"95","author":"Morimoto","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2019.03.002_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/JVI.01309-10","article-title":"Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV","volume":"85","author":"Wirblich","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2019.03.002_bib25","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1073\/pnas.0701397104","article-title":"The dynein light chain 8 binding motif of rabies virus phosphoprotein promotes efficient viral transcription","volume":"104","author":"Tan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2019.03.002_bib26","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.biologicals.2019.03.002_bib27","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/nprot.2013.094","article-title":"Design and generation of recombinant rabies virus vectors","volume":"8","author":"Osakada","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.biologicals.2019.03.002_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1128\/jvi.56.1.12-18.1985","article-title":"Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro","volume":"56","author":"Dietzschold","year":"1985","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2019.03.002_bib29","first-page":"199","article-title":"Antigenic analysis of rabies and mokola virus from Zimbabwe using monoclonal-antibodies","volume":"57","author":"Wiktor","year":"1984","journal-title":"Dev Biologicals"},{"key":"10.1016\/j.biologicals.2019.03.002_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01114-16","article-title":"A full-length infectious cDNA clone of Zika virus from the 2015 Epidemic in Brazil as a genetic platform for studies of virus-Host interactions and vaccine development","volume":"7","author":"Tsetsarkin","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.biologicals.2019.03.002_bib31","article-title":"Deep sequencing for evaluation of genetic stability of influenza A\/California\/07\/2009 (H1N1) vaccine viruses","volume":"10","author":"Laassri","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2019.03.002_bib32","series-title":"Methods of statistical analysis","first-page":"443","author":"Goulden","year":"1956"},{"key":"10.1016\/j.biologicals.2019.03.002_bib33","series-title":"Wiley series in probability and statistics","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/9781118391686.ch10","article-title":"Methods of multivariate analysis. Chapter 10: multivariate regression","author":"Rencher","year":"2012"},{"key":"10.1016\/j.biologicals.2019.03.002_bib34","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0042-6822(90)90433-R","article-title":"Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19","volume":"175","author":"Conzelmann","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2019.03.002_bib35","doi-asserted-by":"crossref","first-page":"7261","DOI":"10.1128\/JVI.74.16.7261-7269.2000","article-title":"Differential transcription attenuation of rabies virus genes by intergenic regions: generation of recombinant viruses overexpressing the polymerase gene","volume":"74","author":"Finke","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2019.03.002_bib36","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1073\/pnas.97.7.3544","article-title":"Recombinant rabies virus as potential live-viral vaccines for HIV-1","volume":"97","author":"Schnell","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biologicals.2019.03.002_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuron.2011.07.005","article-title":"New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits","volume":"71","author":"Osakada","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.biologicals.2019.03.002_bib38","unstructured":"WHO Expert Committee on Rabies. In: reportWHO technical report series 824. Geneva, Switzerland."},{"key":"10.1016\/j.biologicals.2019.03.002_bib39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biologicals.2012.07.005","article-title":"Report on the international workshop on alternative methods for human and veterinary rabies vaccine testing: state of the science and planning the way forward","volume":"40","author":"Stokes","year":"2012","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561830352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104510561830352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:13:41Z","timestamp":1760922821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104510561830352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"alternative-id":["S104510561830352X"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.03.002","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}